Common mutations in the human
prohormone convertase (PC)1/3 gene (PCKSI) are linked to increased risk of
obesity. Previous work has shown that the rs6232 single-nucleotide polymorphism (N221D) results in slightly decreased activity, although whether this decrease underlies
obesity risk is not clear. We observed significantly decreased activity of the N221D PC1/3
enzyme at the pH of the trans-Golgi network; at this pH, the mutant
enzyme was less stable than wild-type
enzyme. Recombinant N221D PC1/3 also showed enhanced susceptibility to heat stress. Enhanced susceptibility to
tunicamycin-induced endoplasmic reticulum stress was observed in AtT-20/PC2 cell clones in which murine PC1/3 was replaced by human N221D PC1/3, as compared with wild-type human PC1/3. However, N221D PC1/3-expressing AtT-20/PC2 clones processed
proopiomelanocortin to α-
MSH similarly to wild-type PC1/3. We also generated a CRISPR-edited mouse line expressing the N221D mutation in the PCKSI gene. When homozygous N221D mice were fed either a standard or a high-fat diet, we found no increase in
body weight compared with their wild-type sibling controls. Sexual dimorphism was observed in pituitary
ACTH for both genotypes, with females exhibiting lower levels of pituitary
ACTH. In contrast, hypothalamic α-
MSH content for both genotypes was higher in females compared with males. Hypothalamic
corticotropin-like intermediate
peptide content was higher in wild-type females compared with wild-type, but not N221D, males. Taken together, these data suggest that the increased
obesity risk linked to the N221D allele in humans may be due in part to PC1/3-induced loss of resilience to stressors rather than strictly to decreased enzymatic activity on
peptide precursors.